Provided by Tiger Trade Technology Pte. Ltd.

Viking Therapeutics

29.52
-0.4300-1.44%
Post-market: 29.650.1300+0.44%17:32 EDT
Volume:3.00M
Turnover:89.35M
Market Cap:3.44B
PE:-6.32
High:30.77
Open:30.02
Low:28.80
Close:29.95
52wk High:43.15
52wk Low:22.96
Shares:116.65M
Float Shares:110.00M
Volume Ratio:1.41
T/O Rate:2.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.6676
EPS(LYR):-3.1920
ROE:-88.85%
ROA:-51.86%
PB:8.43
PE(LYR):-9.25

Loading ...

Earnings Flash (VKTX) Viking Therapeutics Posts Q1 EPS -$1.37, vs. FactSet Est of -$0.98

MT Newswires Live
·
Apr 30

Viking Therapeutics reports Q1 EPS ($1.37), consensus (91c)

TIPRANKS
·
Apr 30

Viking Therapeutics Q1 loss widens on  higher research, development expenses

Reuters
·
Apr 30

Viking Therapeutics Q1 EPS $(1.37) Misses $(1.02) Estimate

Benzinga Earnings
·
Apr 30

BRIEF-Viking Therapeutics Q1 EPS USD -1.37 Vs. IBES Estimate USD -1.01

Reuters
·
Apr 30

Viking Therapeutics Q1 EPS USD -1.37 VS. Ibes Estimate USD -1.01

THOMSON REUTERS
·
Apr 30

Viking Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
Apr 30

U.S. Earnings Preview: After Market Close April 29

Dow Jones
·
Apr 30

Viking Therapeutics options imply 7.0% move in share price post-earnings

TIPRANKS
·
Apr 30

Viking Therapeutics Inc expected to post a loss of $1.01 a share - Earnings Preview

Reuters
·
Apr 28

Viking Therapeutics to report first-quarter results, host conference call

Reuters
·
Apr 23

Top Calls on Wall Street: Nvidia, Apple, Tesla, Alphabet, Cava, Netflix, Airbnb, Viking and More

Tiger Newspress
·
Apr 22

Health Care Up After UnitedHealth Earnings -- Health Care Roundup

Dow Jones
·
Apr 22

Viking Therapeutics to attend Raymond James Biotech/BioPharma Conference in investor meetings

Reuters
·
Apr 10

Viking Therapeutics call volume above normal and directionally bullish

TIPRANKS
·
Apr 10

Viking Therapeutics May Benefit From New Era for Weight Loss Pills, Oppenheimer Says

MT Newswires Live
·
Apr 08

Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX) and Terumo (OtherTRUMF)

TIPRANKS
·
Apr 08

A Look At Viking Therapeutics (VKTX) Valuation As VANQUISH 2 Reaches Full Phase 3 Enrollment

Simply Wall St.
·
Apr 08

Viking Therapeutics (VKTX) Is Up 7.0% After Completing Enrollment In Key VANQUISH-2 Obesity Trial

Simply Wall St.
·
Apr 06

Viking Therapeutics announces annual shareholder meeting webcast and proxy materials availability

Reuters
·
Apr 02